Aurora Cannabis is staking a claim stateside.
The Canadian cannabis heavy hitter announced an all-stock acquisition of U.S. CBD company Reliva last week, which marks Aurora’s first big foray into the enticing U.S. market. But it comes at a time when industrywide bearishness has led many stocks to dramatically sell off—including Aurora, which has shed nearly 90% of its market cap in the past year.